Core Alternative Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55K Hold
600
0.02% 148
2026
Q1
$51.1K Hold
600
0.02% 146
2025
Q4
$47.4K Sell
600
-27
-4% -$2.12K 0.01% 149
2025
Q3
$50.1K Hold
627
0.01% 126
2025
Q2
$57K Hold
627
0.02% 121
2025
Q1
$58.8K Sell
627
-49
-7% -$4.39K 0.01% 125
2024
Q4
$61.5K Hold
676
0.01% 138
2024
Q3
$70.2K Hold
676
0.01% 132
2024
Q2
$65.6K Hold
676
0.01% 135
2024
Q1
$60.9K Sell
676
-361
-35% -$30.6K 0.01% 135
2023
Q4
$82.6K Sell
1,037
-115
-10% -$8.65K 0.01% 142
2023
Q3
$81.9K Buy
1,152
+1
+0.1% +$75 0.01% 156
2023
Q2
$88.7K Buy
1,151
+6
+0.5% +$464 0.01% 126
2023
Q1
$86.1K Buy
1,145
+671
+142% +$49.9K 0.01% 121
2022
Q4
$37.3K Buy
474
+21
+5% +$1.57K ﹤0.01% 174
2022
Q3
$32K Buy
453
+19
+4% +$1.49K 0.01% 177
2022
Q2
$35K Buy
434
+55
+15% +$4.3K 0.01% 172
2022
Q1
$29K Buy
379
+342
+924% +$27.1K 0.01% 183
2021
Q4
$3K Buy
+37
New +$2.89K ﹤0.01% 235

Other funds holding CL

Core Alternative Capital's CL Position: Q2 2026 in Review

Core Alternative Capital held its Colgate-Palmolive (CL) position steady in Q2 2026 at 600 shares worth $55K. The position accounts for 0.02% of the portfolio, ranked #148.

Core Alternative Capital first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $88.7K in Q2 2023. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Core Alternative Capital held 600 shares of Colgate-Palmolive worth $55K as of Q2 2026.
  • Core Alternative Capital left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Core Alternative Capital's portfolio in Q2 2026, its #148 holding.
  • Core Alternative Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • Core Alternative Capital's Colgate-Palmolive position peaked at $88.7K in Q2 2023.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.